Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis

Clinical trial NCT02467608 · COMPLETED

Trial details

NCT number: NCT02467608
Sponsor: Orient Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pulmonary Tuberculosis

Start date: 2012-12-06
Primary completion: 2019-01-09
Enrollment: 557

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.